ASCO GUIDELINES Bundle

Invasive Cervical Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/792921

Contents of this Issue

Navigation

Page 2 of 17

3 Facility Specifications Table 1. Treatment Capacity Treatment Basic Limited Enhanced Maximal Surgery Simple (extrafascial) hysterectomy or more extensive hysterectomy can be performed a Modified radical or radical hysterectomy Capable of performing most major surgeries, including radical hysterectomy, radical trachelectomy, b pelvic and para-aortic LN sampling, and pelvic exenteration. b Following are not available: PET scan, interventional radiolog y, sentinel node biopsy/IORT, or bevacizumab Radical hysterectomy, radical trachelectomy, pelvic and para-aortic LN sampling, sentinel node biopsy, and pelvic exenteration; RT, chemotherapy, interventional radiology, palliative care service, and bevacizumab are all available Chemo- therapy Availability of chemotherapy drugs is unpredictable Chemotherapy may be available Chemotherapy available; bevacizumab not available Chemotherapy available; bevacizumab is available RT No RT available Limited external RT with no brachytherapy available; in some areas where there is only brachytherapy and no external RT, this will be considered as basic level RT including external beam and brachytherapy available; interventional radiolog y not available RT including external beam and brachytherapy available; interventional radiology available

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Invasive Cervical Cancer